We are live on ! Find out more
PTCT icon

PTC Therapeutics
PTCT

148 hedge funds and large institutions have $1.15B invested in PTC Therapeutics in 2018 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 40 increasing their positions, 45 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 18

82% more capital invested

Capital invested by funds: $636M → $1.15B (+$519M)

75% more funds holding in top 10

Funds holding in top 10: 4 → 7 (+3)

18% more funds holding

Funds holding: 125 → 148 (+23)

10.26% more ownership

Funds ownership: 91.86% → 102.12% (+10%)

10% less call options, than puts

Call options by funds: $24.3M | Put options by funds: $27.1M

11% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 45

Holders
148
Holders Change
+23
Holders Change %
+18.4%
% of All Funds
3.39%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.16%
New
42
Increased
40
Reduced
45
Closed
18
Calls
$24.3M
Puts
$27.1M
Net Calls
-$2.81M
Net Calls Change
+$36M

Top Buyers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
+$44.9M
2
BC
Boxer Capital
California
+$21.5M
3
MWNA
Marshall Wace North America
New York
+$16.8M
4
FCM
Frontier Capital Management
Massachusetts
+$13.6M
5
Morgan Stanley
Morgan Stanley
New York
+$12.1M

Top Sellers

Rank Fund Capital Flow
1
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$16M
2
State Street
State Street
Massachusetts
-$14.3M
3
Group One Trading
Group One Trading
Illinois
-$13.3M
4
JGC
J. Goldman & Co
New York
-$10.9M
5
SIM
Spark Investment Management
New York
-$9.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
American Century Companies
51
American Century Companies
Missouri
$2.49M -$2.52M -99,399 -52%
SDIC
52
South Dakota Investment Council
South Dakota
$2.44M -$1.55M -61,200 -40%
AH
53
Aviva Holdings
Bahamas
$2.36M +$2.21M +87,330 New
MIM
54
Monashee Investment Management
Massachusetts
$2.17M +$2.03M +80,000 New
Wells Fargo
55
Wells Fargo
California
$2.15M +$81.1K +3,199 +4%
CM
56
Crestline Management
Texas
$2.1M +$874K +34,509 +80%
ZIG
57
Zuckerman Investment Group
Illinois
$1.99M – – –
Swiss National Bank
58
Swiss National Bank
Switzerland
$1.99M +$203K +8,000 +12%
EAM
59
Eventide Asset Management
Massachusetts
$1.84M – – –
GC
60
Guggenheim Capital
Illinois
$1.77M -$548K -21,619 -25%
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$1.65M -$54.2K -2,141 -3%
CS
62
Credit Suisse
Switzerland
$1.61M +$523K +20,639 +53%
AA
63
ALPS Advisors
Colorado
$1.51M +$245K +9,673 +21%
PG
64
PEAK6 Group
Illinois
$1.5M +$1.4M +55,443 New
JG
65
Jefferies Group
New York
$1.48M +$368K +14,523 +36%
3C
66
361 Capital
Colorado
$1.45M +$1.36M +53,599 New
PAM
67
Panagora Asset Management
Massachusetts
$1.36M +$1.27M +50,320 New
PAMU
68
Pictet Asset Management (UK)
United Kingdom
$1.36M +$1.27M +50,100 New
Hudson Bay Capital Management
69
Hudson Bay Capital Management
Connecticut
$1.35M -$253K -10,000 -17%
AllianceBernstein
70
AllianceBernstein
Tennessee
$1.33M – – –
VEA
71
Virtus ETF Advisers
New York
$1.27M +$638K +25,165 +116%
New York State Common Retirement Fund
72
New York State Common Retirement Fund
New York
$1.24M +$104K +4,100 +10%
Group One Trading
73
Group One Trading
Illinois
$1.17M -$13.3M -526,149 -92%
State of Wisconsin Investment Board
74
State of Wisconsin Investment Board
Wisconsin
$1.09M +$416K +16,400 +68%
California Public Employees Retirement System
75
California Public Employees Retirement System
California
$1.06M +$502K +19,809 +102%
1 2
3
4 5

PTCT Hedge Fund Activity: Q1 2018 in Review

148 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q1 2018, worth a combined $1.15B — up 82% from $636M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new PTCT positions and 18 closed out — a net gain of 24 holders — while 40 added to existing stakes and 45 trimmed.

The largest buyer was Scopia Capital Management, adding an estimated $44.9M. The largest seller was Parallax Volatility Advisers, exiting entirely with an estimated $16M sold.

  • 148 institutional investors held PTC Therapeutics (PTCT) as of Q1 2018, up from 125 in Q4 2017.
  • Funds reported $1.15B of PTC Therapeutics stock for Q1 2018, up 82% quarter-over-quarter.
  • 42 funds opened new PTC Therapeutics positions in Q1 2018 and 18 closed out, a net change of +24 holders.
  • The largest PTC Therapeutics buyer in Q1 2018 was Scopia Capital Management, an estimated $44.9M added.
  • The largest PTC Therapeutics seller in Q1 2018 was Parallax Volatility Advisers, an estimated $16M sold.

Based on aggregated 13F filings for Q1 2018.